PropertyValue
?:definition
  • Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine antibodies to one or more of several retinal proteins found in patients with cancer-associated retinopathy (anti-CAR antibodies). This retinopathy is a rare disease characterized by retinal degeneration and a progressive loss of vision in association with cancer in the absence of metastatic, infectious, or metabolic complications (i.e., a paraneoplastic neurological disease). Reagents to determine anti-CAR antibodies are mainly used in assays intended for early diagnosis of cancer.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3690621_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3690621_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all